|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification Number)
|
|
|
|
(Address of principal executive office)
|
(Zip Code)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
|
|
|
Accelerated Filer ☐
|
Emerging Growth Company
|
Non-accelerated Filer ☐
|
Smaller Reporting Company
|
Page No.
|
||
PART I
|
||
Item 1.
|
3
|
|
Item 1A.
|
13
|
|
Item 1B.
|
19
|
|
Item 1C.
|
20
|
|
Item 2.
|
21
|
|
Item 3.
|
32
|
|
Item 4.
|
32
|
|
PART II
|
||
Item 5.
|
34
|
|
Item 6.
|
[Reserved]
|
38
|
Item 7.
|
38
|
|
Item 7A.
|
49
|
|
Item 8.
|
50
|
|
Item 9.
|
50
|
|
Item 9A.
|
50
|
|
Item 9B.
|
51
|
|
Item 9C.
|
51
|
|
PART III
|
||
Item 10.
|
51
|
|
Item 11.
|
51
|
|
Item 12.
|
52
|
|
Item 13.
|
52
|
|
Item 14.
|
52
|
|
PART IV
|
||
Item 15.
|
53
|
|
57
|
● |
The Consumer & Specialties segment serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions
and technologies that are an essential component of our customers’ finished products.
|
● |
The Engineered Solutions segment serves industrial end markets with engineered systems,
mineral blends, and technologies that are designed to improve our customers’ manufacturing processes and projects.
|
2024
|
2023
|
2022
|
||||||||||
Percentage of Net Sales
|
||||||||||||
Consumer & Specialties
|
54
|
%
|
54
|
%
|
53
|
%
|
||||||
Engineered Solutions
|
46
|
%
|
46
|
%
|
47
|
%
|
||||||
Total
|
100
|
%
|
100
|
%
|
100
|
%
|
•
|
Natural bentonite feed additives to improve animals’ digestive health through gastrointestinal binding of mycotoxins.
|
•
|
Filtration media for edible oil, renewable fuels, and beverages where the Company’s unique mineral reserves and differentiated
process targets removal of specific contaminants.
|
•
|
Agricultural products to improve plant harvests, plant health and soil that enhance crop yield.
|
•
|
Advanced performance additives, including organoclays, used in flame retardants, plastic packaging, rubber mold release,
paints, coatings and ink manufacturing processes.
|
•
|
Gunnable monolithic refractory products and application systems to users of basic oxygen furnaces and electric arc furnaces for
application on furnace walls to prolong the life of furnace linings.
|
•
|
Monolithic refractory materials and pre-cast refractory shapes for iron and steel ladles, vacuum degassers, continuous casting
tundishes, blast furnaces and reheating furnaces.
|
•
|
Refractory shapes and linings to the glass, cement, aluminum, petrochemicals, power generation and other non-steel industries.
|
•
|
In the Household & Personal Care product line, the Company’s research and development efforts employ our functional additive core technologies
to support both our private label and branded products. Our initiatives include formulation development and packaging collaboration with our customers on the development of functional and aesthetically pleasing private label cat litters and
our branded cat litters, including Premium Choice® and SivocatTM. In our personal care product group, we develop and formulate ingredients and delivery systems, including Microsponge® poly beads and Poly-Pore®
and Poly-Trap® polymers which are proprietary systems of microparticles that entrap active ingredients for sustained release to enhance their performance in topical dermatological products. We also collaborate with our customers on
their private label personal care products. Our in-house research & development team specializes in formulation development and collaborates with our partners to create products that meet their specifications. After validation of the
formulas through analytics and stability testing, our packaging engineers evaluate the formula and packaging compatibility. Additionally, our RafinolTM oil purification agents purify and remove contaminates in edible oils and
renewable fuels, including renewable diesel, biodiesel and sustainable aviation fuel; our KWK® bentonite purifies and clarifies wine and juices; and our Enersol® soil enhancer and Agro-Lig® humic acid are
agricultural additives that promote sustainable growth and optimal yield of commercial crops by adding best-in-kind organic materials to the soil. Our research with bentonite clays includes a wide variety of applications including animal
health, fabric care, personal care, paints, ink, asphalt emulsions and coating functional additives.
|
•
|
In the Specialty Additives product line, the Company’s research and development efforts include: the satellite precipitated calcium carbonate (PCC)
and satellite ground calcium carbonate (GCC) plant concepts and applying our crystal engineering core technologies to create specific PCC and GCC particles for paper filling and coating applications, with our FulFill® high filler
technology systems, NewYield® Waste Stream Process Technology, and ENVIROFIL® Waste Stream Process Technology. The FulFill® brand High Filler Technology is a portfolio of high-filler technologies that offers
papermakers a variety of efficient, flexible solutions that decrease dependency on fiber and optimize cost and quality; NewYield® Waste Stream Process Technology cost-effectively converts a pulp mill waste stream into a functional
pigment for paper and packaging filling, while eliminating the cost and environmental impact of disposal and remediation of certain waste streams to papermakers; ENVIROFIL® Waste Stream Process Technology allows cost-effective
recovery of mineral pigments from de-inking waste materials by converting these materials into a functional pigment for filling paper while eliminating the cost and environmental impact of disposal and remediation. Our Specialty PCC and
process mineral solutions include our Thixocarb® PCC, Vicality® USP PCC, EMforceTM calcium carbonate.
|
•
|
In the High Temperature Technologies product line, our main objective is designing products and applications based on customer’s needs using our
engineered blend core technologies. Voice of the customer has driven our achievements in developing our Scantrol® automated gunning technology. This technology combines our industry leading LACAM® laser-based
refractory measurement systems and our MINSCAN® application technology with advance automation software to deliver the safest and most efficient furnace and steel ladle maintenance system in the steel industry. Our SURE-CAL®
calcium metal injection technology provides the most efficient and reliable method of calcium treatment in steelmaking that enhances steel quality and productivity to our customer’s operation. Our DURACRETETM line of shotcretes
and castables provide our customers with the highest performance of refractory and safety against loss of containment. The Company continues to make diligent efforts in providing the safest, highest performance and most effective solutions
required to meet our customer’s needs. Our ADDITROL® greensand bond formulations are custom blends and meet the need of both ferrous and non-ferrous applications. Our Volclay®, MaxibondTM, and Panther Creek®
products are used in green sand molding applications ranging from the production of iron and steel castings to the production of non-ferrous castings. The Hevi-Sand® specialty chromite sand prevents metal penetration and can be
used with most foundry binders in molds and cores.
|
•
|
In the Environmental & Infrastructure product line, particle surface modification core technologies are used to develop products to meet
critical performance criteria for a variety of customers. The Bentomat® and RESISTEXTM lining technologies are engineered to withstand the full continuum of leachate chemistries, including increasingly aggressive
leachates from Mining and Coal Combustion Byproduct applications. We protect the commercial building envelope from water ingress with our waterproofing products, including Voltex® flexible barrier sheets, Core-Flex®
waterproofing membranes, and Waterstop RX® waterproofing compositions, and our Vintegra® membranes, which are our newest innovation for combined waterproofing and gas vapor protection membranes. Additionally, our
company has several advanced water treatment technologies. The Crudesorb® filtration media, CrudeSep® water treatment, Hi-Flow® filtration media, MOST® water treatment system, and ORGANOCLAY
technologies offer highly effective solutions solidifying aqueous waste or for removing oils, greases and other low solubility organic compounds, solids and metals from aqueous streams. The Company’s FLUORO-SORB® adsorbent is a
proprietary, patented, NSF-certified product designed to globally support remediation efforts surrounding per- and polyflouroalkyl substances (PFAS) and Perflourooctane sulfonate (PFOS).
|
Location
|
Facility
|
Product Line
|
Segment
|
|||
United States
|
||||||
Alabama, Sandy Ridge
|
Plant; Mine
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
Alabama, Selma
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Arizona, Phoenix
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Arizona, Pima County (1)
|
Plant; Mine
|
Specialty Additives
|
Consumer & Specialties
|
|||
Arkansas, Ashdown
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
California, Lucerne Valley
|
Plant; Mine
|
Specialty Additives
|
Consumer & Specialties
|
|||
Connecticut, Canaan
|
Plant; Mine
|
Specialty Additives, High-Temperature Technologies
|
All Segments
|
|||
Georgia. Cartersville
|
Plant
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Illinois, Belvidere
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Illinois, Hoffman Estates (2)
|
Research Laboratories; Administrative office
|
All Company Products
|
All Segments
|
|||
Indiana, Portage
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Indiana, Troy
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Iowa, Shell Rock
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Kentucky, Wickliffe
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Louisiana, Baton Rouge
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Louisiana, Broussard
|
Administrative office
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Louisiana, Lafayette
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Louisiana, New Iberia (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Massachusetts, Adams
|
Plant; Mine
|
Specialty Additives
|
Consumer & Specialties
|
|||
Michigan, Albion
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Michigan, Quinnesec
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Minnesota, Cloquet
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Minnesota, International Falls
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Mississippi, Aberdeen
|
Plant
|
Specialty Additives and Environmental & Infrastructure
|
All Segments
|
|||
Missouri, Ste. Genevieve
|
Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Nebraska, Scottsbluff
|
Transportation terminal
|
All Company Products
|
Engineered Solutions
|
|||
New York, New York (2)
|
Headquarters
|
All Company Products
|
Headquarters
|
|||
New York, Ticonderoga
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
North Dakota, Gascoyne
|
Plant; Mine
|
High-Temperature Technologies, Environmental & Infrastructure and Household & Personal Care
|
All Segments
|
|||
Ohio, Archbold
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Ohio, Bryan
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Ohio, Chillicothe
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Ohio, Dover
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Pennsylvania, Bethlehem
|
Administrative Office; Research Laboratories; Sales Offices
|
All Company Products
|
All Segments
|
|||
Pennsylvania, Easton
|
Administrative Office; Research Laboratories; Plant; Sales Offices
|
All Company Products
|
All Segments
|
|||
Pennsylvania, Slippery Rock
|
Plant; Sales Offices
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Pennsylvania, York
|
Plant
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
Location
|
Facility
|
Product Line
|
Segment
|
|||
South Carolina, Eastover
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Tennessee, Chattanooga
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Tennessee, Dyersburg
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Texas, Houston (2)
|
Research Laboratories
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Texas, Houston (2)
|
Administrative Office
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Washington, Longview
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Wisconsin, Neenah
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Wisconsin, Superior
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Wyoming, Colony
|
Plant; Mine
|
High-Temperature Technologies, Environmental & Infrastructure and Household & Personal Care
|
All Segments
|
|||
Wyoming, Lovell
|
Plant; Mine
|
High-Temperature Technologies, Environmental & Infrastructure and Household & Personal Care
|
All Segments
|
Location
|
Facility
|
Product Line
|
Segment
|
|||
International
|
||||||
Australia, Brisbane
|
Sales Office/Administrative Office
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
Australia, Oak Flats (2)
|
Sales Office
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Australia, Gurulmundi
|
Plant; Mine
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
Australia, Perth (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Austria, Pucking
|
Sales Office/Administrative Office
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Austria, Rottersdorf
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Belgium, Brussels
|
Administrative Office
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Brazil, Guaiba
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Brazil, Jacarei
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Brazil, Luiz Antonio
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Brazil, Macae (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Brazil, Mucuri
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Brazil, Sao Jose dos Campos
|
Sales Office /Administrative Office
|
Specialty Additives
|
Consumer & Specialties
|
|||
Brazil, Suzano
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Canada, Brantford, Ontario
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Canada, Lethbridge, Alberta
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Canada, Mississauga, Ontario
|
Administrative Office
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Canada, Pt. Claire
|
Administrative Office
|
Specialty Additives/High-Temperature Technologies
|
All Segments
|
|||
Canada, St. Jerome, Quebec
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Canada, Windsor, Quebec
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Beihai
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Beihai (New Yield) (4)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Beijing
|
Sales Office/Administrative Office
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
China, Chao Yang, Liaoning
|
Plant; Mine
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
China, Changshu
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Dagang (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Henan
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Rugao
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Shandong
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Shanghai
|
Administrative Office/Sales Office
|
Specialty Additives/High-Temperature Technologies
|
All Segments
|
Location
|
Facility
|
Product Line
|
Segment
|
|||
China, Shouguang (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Suzhou
|
Plant
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
China, Suzhou
|
Sales Office/Research Laboratories
|
Specialty Additives/High-Temperature Technologies
|
All Segments
|
|||
China, Taian (4)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Tianjin
|
Plant; Mine; Research Laboratories
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
China, Yanzhou
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Zhejiang (4)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
China, Zhumadian
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Finland, Äänekoski
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Finland, Tervakoski
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
France, Quimperle
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
France, Saillat Sur Vienne
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Germany, Duisburg
|
Plant/Sales Office/Research Laboratories
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Germany, Schongau
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Netherlands, Hengelo
|
Plant/Administrative Office
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
India, Ballarshah (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Chennai
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
India, Dandeli
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Erode
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Gaganapur (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Kala Amb
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Mukstar
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Mumbai (2)
|
Sales Office /Administrative Office
|
Specialty Additives/High-Temperature Technologies
|
All Segments
|
|||
India, Lalkuan
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Rajahmundry
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Rayagada (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Saila Khurd
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
India, Sirpur (4)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Indonesia, Jakarta (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Indonesia, Perawang (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Indonesia, Perawang 2 (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Ireland, Cork (2)
|
Plant; Administrative Office/ Research Laboratories
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Italy, Brescia
|
Sales Office
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Italy, Nave
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Japan, Gamagori
|
Plant/Research laboratories
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Japan, Shiraoi (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Japan, Tokyo
|
Sales/Administrative Office
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Malaysia, Kemaman (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Malaysia, Labuan (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Malaysia, Puchong (2)
|
Sales Office/Administrative Office
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Malaysia, Sipitang
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Netherlands, Moerdijk
|
Plant/Administrative Office
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Nigeria, Port Harcourt (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
Location
|
Facility
|
Product Line
|
Segment
|
|||
Poland, Kwidzyn
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Poland, Szczytno
|
Plant
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
Portugal, Figueira da Foz (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Slovakia, Bratislava
|
Administrative Office; Mine
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Slovakia, Kopernica
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Slovakia, Ruzomberok
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
South Africa, Johannesburg (2)
|
Sales Office/Administrative Office
|
High-Temperature Technologies and Specialty Additives
|
All Segments
|
|||
South Africa, Merebank (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
South Africa, Pietermaritzburg
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
South Korea, Yangbuk-Myeun, Kyeung-buk
|
Plant
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
Spain, Santander
|
Administrative Office
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Thailand, Laemchabang
|
Plant
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
Thailand, Namphong
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Thailand, Tha Toom (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Thailand, Tha Toom 2 (3)
|
Satellite Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
Thailand, Wangnoi
|
Plant
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Turkey, Enez
|
Plant; Mine
|
High-Temperature Technologies, Environmental & Infrastructure and Household & Personal Care
|
All Segments
|
|||
Turkey, Gebze
|
Plant/Research Laboratories
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Turkey, Istanbul
|
Sales Office/Administrative Office
|
High-Temperature Technologies and Household & Personal Care
|
All Segments
|
|||
Turkey, Kutahya
|
Plant
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
Turkey, Unye
|
Plant; Mine
|
Household & Personal Care
|
Consumer & Specialties
|
|||
Turkey, Usak
|
Plant; Mine
|
Household & Personal Care
|
Consumer & Specialties
|
|||
United Kingdom, Aberdeen (2)
|
Operations base
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
United Kingdom, Birkenhead (2)
|
Research Laboratories
|
Environmental & Infrastructure
|
Engineered Solutions
|
|||
United Kingdom, Lifford
|
Plant
|
Specialty Additives
|
Consumer & Specialties
|
|||
United Kingdom, Rotherham
|
Plant/Sales Office
|
High-Temperature Technologies
|
Engineered Solutions
|
|||
United Kingdom, Winsford
|
Plant/Research Laboratories
|
Household & Personal Care and High-Temperature Technologies
|
All Segments
|
(1) |
This plant and quarry is leased to another company.
|
(2) |
Leased by the Company. The facilities in Cork, Ireland, are operated pursuant to a 99-year lease, the term of which commenced in 1963. The Company’s headquarters in New
York, New York, are held under a lease which expires in 2031.
|
(3) |
These plants are owned through joint ventures.
|
(4) |
These plants are under construction.
|
2024
|
2023
|
2022
|
||||||||||
Tons (000s)
|
Tons (000s)
|
Tons (000s)
|
||||||||||
Limestone
|
||||||||||||
Adams, MA
|
298
|
401
|
315
|
|||||||||
Canaan, CT
|
674
|
641
|
562
|
|||||||||
Lucerne Valley, CA
|
1,262
|
1,267
|
1,202
|
|||||||||
Pima County, AZ
|
101
|
101
|
114
|
|||||||||
Total Limestone
|
2,335
|
2,410
|
2,193
|
|||||||||
Sodium Bentonite
|
||||||||||||
Australia
|
61
|
39
|
69
|
|||||||||
Belle/Colony, WY/SD
|
1,540
|
1,253
|
1,109
|
|||||||||
Lovell, WY
|
760
|
681
|
629
|
|||||||||
Total Sodium Bentonite
|
2,361
|
1,973
|
1,807
|
|||||||||
Calcium Bentonite
|
||||||||||||
Chao Yang, Liaoning, China
|
461
|
278
|
267
|
|||||||||
Nevada
|
1
|
1
|
1
|
|||||||||
Sandy Ridge, AL
|
104
|
96
|
98
|
|||||||||
Slovakia, Lutila
|
74
|
65
|
52
|
|||||||||
Turkey, Enez
|
188
|
168
|
172
|
|||||||||
Turkey, Usak
|
70
|
60
|
62
|
|||||||||
Turkey, Unye
|
386
|
368
|
331
|
|||||||||
Total Calcium Bentonite
|
1,284
|
1,036
|
983
|
|||||||||
Leonardite
|
||||||||||||
Gascoyne, ND
|
41
|
75
|
31
|
|||||||||
GRAND TOTALS (1)
|
6,021
|
5,494
|
5,014
|
(1) |
The Company also has mined, beneficiated and processed talc through its BMI Oldco Inc. (f/k/a Barretts Minerals Inc.) (“Oldco”) subsidiary in prior years. In the fourth
quarter of 2023, Oldco filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code, and Oldco was deconsolidated from our consolidated financial statements. See Note 17 to the consolidated financial statements.
|
Proven and Probable Reserves (1)(2) Tons
(000s)
|
||||||||||||||||||||||||
Proven Reserves (1)(2) Tons (000s)
|
Probable Reserves (1)(2) Tons
(000s)
|
Conversion Factor (%)
|
Owned
|
Unpatented (3)
|
Leased
|
|||||||||||||||||||
Limestone
|
||||||||||||||||||||||||
Adams, MA
|
6,483
|
913
|
56
|
%
|
7,396
|
—
|
—
|
|||||||||||||||||
Canaan, CT
|
14,287
|
4,288
|
97
|
%
|
18,575
|
—
|
—
|
|||||||||||||||||
Lucerne Valley, CA
|
26,420
|
7,399
|
95
|
%
|
33,819
|
—
|
—
|
|||||||||||||||||
Pima County, AZ
|
6,327
|
—
|
90
|
%
|
—
|
6,327
|
—
|
|||||||||||||||||
Total Limestone
|
53,517
|
12,600
|
59,790
|
6,327
|
—
|
|||||||||||||||||||
90
|
%
|
10
|
%
|
0
|
%
|
|||||||||||||||||||
Sodium Bentonite
|
||||||||||||||||||||||||
Australia
|
—
|
952
|
80
|
%
|
—
|
—
|
952
|
|||||||||||||||||
Belle/Colony, WY/SD
|
28,856
|
24,369
|
77
|
%
|
3,399
|
11,869
|
37,957
|
|||||||||||||||||
Lovell, WY
|
29,968
|
4,217
|
87
|
%
|
14,988
|
15,023
|
4,174
|
|||||||||||||||||
Other SD, WY, MT
|
43,117
|
29,714
|
77
|
%
|
54,815
|
15,048
|
2,968
|
|||||||||||||||||
Total Sodium Bentonite
|
101,941
|
59,252
|
73,202
|
41,940
|
46,051
|
|||||||||||||||||||
45
|
%
|
26
|
%
|
29
|
%
|
|||||||||||||||||||
Calcium Bentonite
|
||||||||||||||||||||||||
Chao Yang, Liaoning, China
|
140
|
379
|
78
|
%
|
—
|
—
|
519
|
|||||||||||||||||
Nevada
|
—
|
1,054
|
75
|
%
|
1,010
|
44
|
—
|
|||||||||||||||||
Sandy Ridge, AL
|
4,292
|
2,009
|
75
|
%
|
1,839
|
—
|
4,462
|
|||||||||||||||||
Slovakia, Lutila
|
947
|
1,702
|
84
|
%
|
—
|
—
|
2,649
|
|||||||||||||||||
Turkey, Enez
|
581
|
1,745
|
78
|
%
|
—
|
—
|
2,326
|
|||||||||||||||||
Turkey, Usak
|
801
|
962
|
43
|
%
|
—
|
—
|
1,763
|
|||||||||||||||||
Turkey, Unye
|
—
|
4,843
|
80
|
%
|
—
|
—
|
4,843
|
|||||||||||||||||
Total Calcium Bentonite
|
6,761
|
12,694
|
2,849
|
44
|
16,562
|
|||||||||||||||||||
15
|
%
|
—
|
85
|
%
|
||||||||||||||||||||
Leonardite
|
||||||||||||||||||||||||
Gascoyne, ND
|
158
|
2,158
|
67
|
%
|
—
|
2,158
|
158
|
|||||||||||||||||
0
|
%
|
93
|
%
|
7
|
%
|
|||||||||||||||||||
Chromite
|
||||||||||||||||||||||||
South Africa
|
2,113
|
1,001
|
75
|
%
|
—
|
—
|
3,114
|
|||||||||||||||||
0
|
%
|
0
|
%
|
100
|
%
|
|||||||||||||||||||
GRAND TOTALS
|
164,490
|
87,705
|
135,841
|
50,469
|
65,885
|
|||||||||||||||||||
54
|
%
|
20
|
%
|
26
|
%
|
(1)
|
Certain definitions:
|
(2) |
Mineral reserves estimates were calculated and prepared by the Company’s in-house technical staff.
|
(3) |
Quantity of reserves that would be owned if patent was granted.
|
Total Resources (1)(2)
Tons (000s)
|
||||||||||||||||||||||||||||
Measured Resources (1)(2)
Tons (000s)
|
Indicated Resources (1)(2)
Tons (000s)
|
Measured and Indicated (1)(2) Resources
Tons (000s)
|
Inferred (1)(2) Resources
Tons (000s)
|
Owned
|
Unpatented (3)
|
Leased
|
||||||||||||||||||||||
Limestone
|
||||||||||||||||||||||||||||
Adams, MA
|
24,416
|
1,350
|
25,766
|
14,649
|
40,415
|
—
|
—
|
|||||||||||||||||||||
Canaan, CT
|
15,503
|
21,063
|
36,566
|
3,798
|
40,364
|
—
|
—
|
|||||||||||||||||||||
Lucerne Valley, CA
|
24,825
|
22,373
|
47,198
|
8,394
|
55,592
|
—
|
—
|
|||||||||||||||||||||
Pima County, AZ
|
7,142
|
—
|
7,142
|
—
|
—
|
7,142
|
—
|
|||||||||||||||||||||
Total Limestone
|
71,886
|
44,786
|
116,672
|
26,841
|
136,371
|
7,142
|
—
|
|||||||||||||||||||||
95
|
%
|
5
|
%
|
0
|
%
|
|||||||||||||||||||||||
Sodium Bentonite
|
||||||||||||||||||||||||||||
Australia
|
—
|
1,220
|
1,220
|
—
|
—
|
—
|
1,220
|
|||||||||||||||||||||
Belle/Colony, WY/SD
|
9,407
|
6,902
|
16,309
|
94
|
556
|
8,137
|
7,710
|
|||||||||||||||||||||
Lovell, WY
|
410
|
57
|
467
|
2,952
|
1,075
|
2,217
|
127
|
|||||||||||||||||||||
Other SD, WY, MT
|
4,612
|
—
|
4,612
|
11,030
|
—
|
15,642
|
—
|
|||||||||||||||||||||
Total Sodium Bentonite
|
14,429
|
8,179
|
22,608
|
14,076
|
1,631
|
25,996
|
9,057
|
|||||||||||||||||||||
4
|
%
|
71
|
%
|
25
|
%
|
|||||||||||||||||||||||
Calcium Bentonite
|
||||||||||||||||||||||||||||
Chao Yang, Liaoning, China
|
—
|
200
|
200
|
345
|
—
|
—
|
545
|
|||||||||||||||||||||
Nevada
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||
Sandy Ridge, AL
|
195
|
—
|
195
|
—
|
—
|
—
|
195
|
|||||||||||||||||||||
Slovakia, Lutila
|
—
|
4,113
|
4,113
|
1,892
|
—
|
—
|
6,005
|
|||||||||||||||||||||
Turkey, Enez
|
350
|
—
|
350
|
1,192
|
—
|
—
|
1,542
|
|||||||||||||||||||||
Turkey, Usak
|
580
|
229
|
809
|
2,749
|
—
|
—
|
3,558
|
|||||||||||||||||||||
Turkey, Unye
|
—
|
1,320
|
1,320
|
21,000
|
—
|
—
|
22,320
|
|||||||||||||||||||||
Total Calcium Bentonite
|
1,125
|
5,862
|
6,987
|
27,178
|
—
|
—
|
34,165
|
|||||||||||||||||||||
0
|
%
|
0
|
%
|
100
|
%
|
|||||||||||||||||||||||
Leonardite
|
||||||||||||||||||||||||||||
Gascoyne, ND
|
1,435
|
—
|
1,435
|
790
|
—
|
—
|
2,225
|
|||||||||||||||||||||
0
|
%
|
0
|
%
|
100
|
%
|
|||||||||||||||||||||||
Chromite
|
||||||||||||||||||||||||||||
South Africa
|
800
|
584
|
1,384
|
7,093
|
—
|
—
|
8,477
|
|||||||||||||||||||||
0
|
%
|
0
|
%
|
100
|
%
|
|||||||||||||||||||||||
Other
|
||||||||||||||||||||||||||||
Nevada
|
—
|
2,997
|
2,997
|
3,031
|
—
|
6,028
|
—
|
|||||||||||||||||||||
0
|
%
|
100
|
%
|
0
|
%
|
|||||||||||||||||||||||
GRAND TOTALS
|
89,675
|
62,408
|
152,083
|
79,009
|
138,002
|
39,166
|
53,924
|
|||||||||||||||||||||
60
|
%
|
17
|
%
|
23
|
%
|
(1)
|
Certain definitions:
|
(2) |
Mineral resources estimates were calculated and prepared by the Company’s in-house technical staff.
|
(3) |
Quantity of resources that would be owned if patent was granted.
|
Name
|
Age
|
Position
|
||
Douglas T. Dietrich
|
55
|
Chairman of the Board and Chief Executive Officer
|
||
Erik C. Aldag
|
40
|
Senior Vice President, Finance and Treasury, and Chief Financial Officer
|
||
Brett Argirakis
|
60
|
Group President, Engineered Solutions
|
||
Michael A. Cipolla
|
67
|
Vice President, Corporate Controller and Chief Accounting Officer
|
||
Erin N. Cutler
|
37
|
Vice President, Human Resources
|
||
Jonathan J. Hastings
|
62
|
Senior Vice President, Strategy and M&A
|
||
Timothy J. Jordan
|
50
|
Vice President, General Counsel, Secretary and Chief Compliance Officer
|
||
D.J. Monagle, III
|
62
|
Group President, Consumer & Specialties
|
Total Number of Shares Purchased
|
Average Price Paid Per Share
|
Total Number of Shares Purchased as Part of the Publicly Announced Program
|
Dollar Value of Shares that May Yet be Purchased Under the Program
|
|||||||||||||
September 30 - October 27
|
44,182
|
$
|
76.49
|
1,034,692
|
$
|
4,233
|
||||||||||
Total
|
44,182
|
$
|
76.49
|
|||||||||||||
October 28 - November 24
|
—
|
$
|
—
|
—
|
$
|
200,000,000
|
||||||||||
November 25 - December 31
|
34,934
|
$
|
79.27
|
34,934
|
$
|
197,230,926
|
||||||||||
Total
|
34,934
|
$
|
79.27
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|||||||||||||||||||
Minerals Technologies Inc.
|
$
|
100.00
|
$
|
108.19
|
$
|
127.74
|
$
|
106.37
|
$
|
125.47
|
$
|
134.81
|
||||||||||||
S&P SmallCap 600
|
100.00
|
111.29
|
141.13
|
118.41
|
137.42
|
149.37
|
||||||||||||||||||
Russell 2000
|
100.00
|
119.96
|
137.74
|
109.59
|
128.14
|
142.93
|
||||||||||||||||||
Dow Jones US Basic Materials
|
100.00
|
118.32
|
151.20
|
139.75
|
155.14
|
146.90
|
2021
|
2022
|
2023
|
2024
|
|||||||||||||
Minerals Technologies Inc.
|
$
|
100.00
|
$
|
83.27
|
$
|
98.22
|
$
|
105.54
|
||||||||
S&P SmallCap 600
|
100.00
|
83.90
|
97.37
|
105.84
|
||||||||||||
Russell 2000
|
100.00
|
79.56
|
93.03
|
103.77
|
||||||||||||
Dow Jones US Basic Materials
|
100.00
|
92.43
|
102.61
|
97.16
|
2023
|
2024
|
|||||||
Minerals Technologies Inc.
|
$
|
100.00
|
$
|
107.45
|
||||
S&P SmallCap 600
|
100.00
|
108.70
|
||||||
Russell 2000
|
100.00
|
111.54
|
||||||
Dow Jones US Basic Materials
|
100.00
|
94.69
|
● |
Increase our presence and market share in global pet litter products, including in emerging markets.
|
● |
Deploy new products in pet care such as lightweight litter.
|
● |
Increase our sales of calcium carbonate products by further penetration into filling and coating applications in the paper and packaging markets.
|
● |
Promote the Company’s expertise in crystal engineering by developing crystal morphologies that help our customers achieve functional benefits.
|
● |
Deploy new calcium carbonate products in paint, coating and packaging applications.
|
● |
Continue developing products and processes for waste management and recycling opportunities to reduce the environmental impact for our customers by reducing energy
consumption and improving the sustainability of their products.
|
● |
Continue to develop innovative applications for our bleaching earth products for edible oil and renewable fuel industries.
|
● |
Develop new mineral-based solutions for personal care applications.
|
● |
Increase our presence and market share globally for retinol delivery technology for personal care applications.
|
● |
Expand our bentonite product solutions for animal health applications.
|
● |
Increase our presence and market share in fabric care, including in emerging markets.
|
● |
Increase our presence and gain penetration of our bentonite-based foundry solutions in emerging markets.
|
● |
Deploy value-added formulations of refractory materials that not only reduce costs but improve performance.
|
● |
Deploy our laser measurement technologies into new applications.
|
● |
Expand our refractory maintenance model to other steel makers globally.
|
● |
Continue the development and market penetration of our FLUORO-SORB® products which address PFAS contamination in soil, groundwater, drinking water sources,
landfill leachate and wastewater treatment facilities.
|
● |
Pursue opportunities for the expanded use of our products in environmental, building and construction, infrastructure, and oil and gas drilling and water treatment
globally.
|
● |
Increase our presence and market share for geosynthetic clay liners globally.
|
● |
Further operational excellence principles into all aspects of the organization, including system infrastructure and lean principles.
|
● |
Continue to explore selective acquisitions to fit our competencies in minerals and our core technologies.
|
Year Ended December 31,
|
||||||||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||||||||||
Net sales
|
$
|
2,118.5
|
$
|
2,169.9
|
$
|
2,125.5
|
(2.4
|
)%
|
2.1
|
%
|
||||||||||
Cost of goods sold
|
1,570.8
|
1,662.8
|
1,660.5
|
(5.5
|
)%
|
0.1
|
%
|
|||||||||||||
Production margin
|
547.7
|
507.1
|
465.0
|
8.0
|
%
|
9.1
|
%
|
|||||||||||||
Production margin %
|
25.9
|
%
|
23.4
|
%
|
21.9
|
%
|
||||||||||||||
Marketing and administrative expenses
|
209.2
|
206.0
|
192.1
|
1.6
|
%
|
7.2
|
%
|
|||||||||||||
Research and development expenses
|
23.0
|
21.2
|
20.4
|
8.5
|
%
|
3.9
|
%
|
|||||||||||||
Provision for credit losses
|
30.0
|
—
|
—
|
*
|
*
|
|||||||||||||||
Restructuring and other items, net
|
—
|
6.9
|
—
|
*
|
*
|
|||||||||||||||
Impairment of assets
|
—
|
71.7
|
—
|
*
|
*
|
|||||||||||||||
Acquisition-related expenses
|
—
|
0.3
|
5.1
|
*
|
(94.1
|
)%
|
||||||||||||||
Gain on sale of assets, net
|
(12.3
|
)
|
—
|
—
|
*
|
*
|
||||||||||||||
Litigation expenses
|
11.3
|
29.2
|
32.6
|
(61.3
|
)%
|
(10.4
|
)%
|
|||||||||||||
Income from operations
|
286.5
|
171.8
|
214.8
|
66.8
|
%
|
(20.0
|
)%
|
|||||||||||||
Operating margin %
|
13.5
|
%
|
7.9
|
%
|
10.1
|
%
|
||||||||||||||
Interest expense, net
|
(56.4
|
)
|
(59.2
|
)
|
(43.9
|
)
|
(4.7
|
)%
|
34.9
|
%
|
||||||||||
Debt extinguishment expenses
|
(1.8
|
)
|
—
|
(6.9
|
)
|
*
|
*
|
|||||||||||||
Non-cash pension settlement charge
|
—
|
—
|
(3.5
|
)
|
*
|
*
|
||||||||||||||
Other non-operating deductions, net
|
(4.7
|
)
|
(4.9
|
)
|
(3.8
|
)
|
(4.1
|
)%
|
28.9
|
%
|
||||||||||
Total non-operating deductions, net
|
(62.9
|
)
|
(64.1
|
)
|
(58.1
|
)
|
(1.9
|
)%
|
10.3
|
%
|
||||||||||
Income before tax and equity in earnings
|
223.6
|
107.7
|
156.7
|
107.6
|
%
|
(31.3
|
)%
|
|||||||||||||
Provision for taxes on income
|
59.4
|
23.7
|
32.1
|
150.6
|
%
|
(26.2
|
)%
|
|||||||||||||
Effective tax rate
|
26.6
|
%
|
22.0
|
%
|
20.5
|
%
|
||||||||||||||
Equity in earnings of affiliates, net of tax
|
6.7
|
4.3
|
1.7
|
55.8
|
%
|
152.9
|
%
|
|||||||||||||
Consolidated net income
|
170.9
|
88.3
|
126.3
|
93.5
|
%
|
(30.1
|
)%
|
|||||||||||||
Less: Net income attributable to non-controlling interests
|
3.8
|
4.2
|
4.1
|
(9.5
|
)%
|
2.4
|
%
|
|||||||||||||
Net income attributable to Minerals Technologies Inc. (MTI)
|
$
|
167.1
|
$
|
84.1
|
$
|
122.2
|
98.7
|
%
|
(31.2
|
)%
|
* |
Not meaningful
|
Year Ended December 31,
|
||||||||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||||||||||
U.S.
|
$
|
1,089.4
|
$
|
1,144.0
|
$
|
1,135.6
|
(4.8
|
)%
|
0.7
|
%
|
||||||||||
International
|
1,029.1
|
1,025.9
|
989.9
|
0.3
|
%
|
3.6
|
%
|
|||||||||||||
Total sales
|
$
|
2,118.5
|
$
|
2,169.9
|
$
|
2,125.5
|
(2.4
|
)%
|
2.1
|
%
|
||||||||||
Consumer & Specialties Segment
|
$
|
1,140.2
|
$
|
1,160.2
|
$
|
1,124.6
|
(1.7
|
)%
|
3.2
|
%
|
||||||||||
Engineered Solutions Segment
|
978.3
|
1,009.7
|
1,000.9
|
(3.1
|
)%
|
0.9
|
%
|
|||||||||||||
Total sales
|
$
|
2,118.5
|
$
|
2,169.9
|
$
|
2,125.5
|
(2.4
|
)%
|
2.1
|
%
|
Year Ended December 31,
|
||||||||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||||||||||
Net Sales
|
||||||||||||||||||||
Household & Personal Care
|
$
|
530.0
|
$
|
517.6
|
$
|
476.2
|
$
|
12.4
|
$
|
41.4
|
||||||||||
Specialty Additives
|
610.2
|
642.6
|
648.4
|
(32.4
|
)
|
(5.8
|
)
|
|||||||||||||
Total net sales
|
$
|
1,140.2
|
$
|
1,160.2
|
$
|
1,124.6
|
$
|
(20.0
|
)
|
$
|
35.6
|
|||||||||
Income from operations
|
$
|
165.5
|
$
|
41.6
|
$
|
79.0
|
$
|
123.9
|
$
|
(37.4
|
)
|
|||||||||
% of net sales
|
14.5
|
%
|
3.6
|
%
|
7.0
|
%
|
Year Ended December 31,
|
||||||||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
2024 vs. 2023
|
2023 vs. 2022
|
|||||||||||||||
Net Sales
|
||||||||||||||||||||
High-Temperature Technologies
|
$
|
713.2
|
$
|
720.9
|
$
|
702.5
|
$
|
(7.7
|
)
|
$
|
18.4
|
|||||||||
Environmental & Infrastructure
|
265.1
|
288.8
|
298.4
|
(23.7
|
)
|
(9.6
|
)
|
|||||||||||||
Total net sales
|
$
|
978.3
|
$
|
1,009.7
|
$
|
1,000.9
|
$
|
(31.4
|
)
|
$
|
8.8
|
|||||||||
Income from operations
|
$
|
174.0
|
$
|
147.8
|
$
|
147.1
|
$
|
26.2
|
$
|
0.7
|
||||||||||
% of net sales
|
17.8
|
%
|
14.6
|
%
|
14.7
|
%
|
● |
Significant under-performance relative to historical or projected future operating results;
|
● |
Significant changes in the manner of use of the acquired assets or the strategy for the overall business;
|
● |
Significant negative industry or economic trends;
|
● |
Market capitalization below invested capital.
|
Plan Category
|
Number of Securities to
be Issued Upon Exercise
of Outstanding Options,
Warrants and Rights(1)
|
Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights (2)
|
Number of Securities
Remaining Available
for Future Issuance
under Equity
Compensation Plans
(excluding securities
reflected in column (a))
|
|||||||||
(a)
|
(b)
|
(c)
|
||||||||||
Equity compensation plans approved by security holders
|
1,624,430
|
$
|
65.06
|
1,419,611
|
||||||||
Total
|
1,624,430
|
$
|
65.06
|
1,419,611
|
(1) |
Includes shares issuable upon exercise of outstanding stock options and shares issuable upon vesting of time-based deferred restricted stock units (DRSUs).
|
(2) |
The weighted-average exercise price includes all outstanding stock options but does not include DRSUs which do not have an exercise price.
|
(a) |
The following documents are filed as part of this report:
|
1. |
Financial Statements. The following Consolidated Financial Statements of Mineral Technologies Inc. and subsidiary companies and Reports of Independent Registered Public
Accounting Firm are set forth on pages F-2 to F-41.
|
2. |
Financial Statement Schedule. The following financial statement schedule is filed as part of this report:
|
3. |
Exhibits. The following exhibits are filed as part of, or incorporated by reference into, this report.
|
Exhibit No.
|
Exhibit Title
|
|
Restated Certificate of Incorporation of the Company (Incorporated by reference to exhibit 3.1 filed with the Company’s Annual Report on Form 10-K
(file no. 001-11430) for the year ended December 31, 2003)
|
||
By-Laws of the Company as amended and restated effective March 13, 2018 (Incorporated by reference to exhibit 3.1 filed with the Company’s Current
Report on Form 8-K (file no. 001-11430) filed on March 19, 2018)
|
||
Specimen Certificate of Common Stock (Incorporated by reference to exhibit 4.1 filed with the Company’s Annual Report on Form 10-K (file no.
001-11430) for the year ended December 31, 2003)
|
||
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Incorporated by reference to
exhibit 4.2 filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2019)
|
||
Indenture, dated as of June 30, 2020, by and among Minerals Technologies
Inc., the subsidiary guarantors from time to time party thereto and The Bank of New York Mellon Trust Company, N.A., as a trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K (file no.
001-11430) filed on June 30, 2020.)
|
||
10.1
|
Asset Purchase Agreement, dated as of September 28, 1992, by and between Specialty Refractories Inc. and Quigley Company Inc. (Incorporated by
reference to the exhibit so designated filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-51292), originally filed on August 25, 1992)
|
|
10.1(a)
|
Agreement dated October 22, 1992 between Specialty Refractories Inc. and Quigley Company Inc., amending Exhibit 10.1 (Incorporated by reference to
the exhibit so designated filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-59510), originally filed on March 15, 1993)
|
|
10.1(b)
|
Letter Agreement dated October 29, 1992 between Specialty Refractories Inc. and Quigley Company Inc., amending Exhibit 10.1 (Incorporated by
reference to the exhibit so designated filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-59510), originally filed on March 15, 1993)
|
|
10.2
|
Reorganization Agreement, dated as of September 28, 1992, by and between the Company and Pfizer Inc. (Incorporated by reference to the exhibit so
designated filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-51292), originally filed on August 25, 1992)
|
|
10.3
|
Asset Contribution Agreement, dated as of September 28, 1992, by and between Pfizer Inc. and Specialty Minerals Inc. (Incorporated by reference to
the exhibit so designated filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-51292), originally filed on August 25, 1992)
|
|
10.4
|
Asset Contribution Agreement, dated as of September 28, 1992, by and between Pfizer Inc. and Barretts Minerals Inc. (Incorporated by reference to the
exhibit so designated filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-51292), originally filed on August 25, 1992)
|
|
10.4(a)
|
Agreement dated October 22, 1992 between Pfizer Inc, Barretts Minerals Inc. and Specialty Minerals Inc., amending Exhibits 10.3 and 10.4
(Incorporated by reference to the exhibit so designated filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-59510), originally filed on March 15, 1993)
|
Employment Agreement, dated December 13, 2016, between the Company and Douglas T. Dietrich (Incorporated by reference to exhibit 10.1 filed with the
Company’s Current Report on Form 8-K (file no. 001-11430) filed on December 16, 2016) (+)
|
||
First Amendment to Employment Agreement, dated April 15, 2021, between the Company and Douglas T. Dietrich (Incorporated by reference to exhibit 10.1
filed with the Company’s Quarterly Report on Form 10-Q (file no. 001-11430) for the quarter ended April 4, 2021) (+)
|
||
Form of Employment Agreement between the Company and each of Erik C. Aldag, Brett Argirakis, Michael A. Cipolla, Erin N. Cutler, Jonathan J.
Hastings, Timothy J. Jordan, and D.J. Monagle, III (Incorporated by reference to exhibit 10.6 filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2016) (+)
|
||
Severance Agreement between the Company and Douglas T. Dietrich (Incorporated by reference to the exhibit 10.2 filed with the Company’s Current
Report on form 8-K (file no. 001-11430) filed on December 16, 2016) (+)
|
||
First Amendment to Severance Agreement between the Company and Douglas T. Dietrich (Incorporated by reference to exhibit 10.2 filed with the
Company’s Quarterly Report on Form 10-Q (file no. 001-11430) for the quarter ended April 4, 2021) (+)
|
||
Form of Severance Agreement between the Company and each of Erik C. Aldag, Brett Argirakis, Michael A. Cipolla, Erin N. Cutler, Jonathan J. Hastings,
Timothy J. Jordan, and D.J. Monagle, III (Incorporated by reference to exhibit 10.8 filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2016) (+)
|
||
Form of Indemnification Agreement between the Company and each of Erik C. Aldag, Brett Argirakis, Michael A. Cipolla, Erin N. Cutler, Douglas T.
Dietrich, Jonathan J. Hastings, Timothy J. Jordan, D.J. Monagle III and each of the Company’s non-employee directors (Incorporated by reference to exhibit 10.1 filed with the Company’s Current Report on Form 8-K (file no. 001-11430) filed on
May 8, 2009) (+)
|
||
Company Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors, as amended and restated effective January 1, 2008
(Incorporated by reference to exhibit 10.8 filed with the Company’s Quarterly Report on Form 10-Q (file no. 001-11430) for the quarter ended March 30, 2008) (+)
|
||
First Amendment to the Company Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors, dated January 18, 2012 (Incorporated
by reference to exhibit 10.11(a) filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2011) (+)
|
||
2015 Stock Award and Incentive Plan of the Company, as amended and restated effective March 15, 2024 (Incorporated by reference to Appendix B to the
Company’s 2024 Proxy Statement (file no. 001-11430) filed on April 4, 2024) (+)
|
||
Form of Stock Option Agreement (Incorporated by reference to exhibit 10.12(a) filed with the Company’s Annual Report on Form 10-K (file no.
001-11430) for the year ended December 31, 2019) (+)
|
||
Form of Deferred Restricted Stock Unit Agreement (Incorporated by reference to exhibit 10.12(b) filed with the Company’s Annual Report on Form 10-K
(file no. 001-11430) for the year ended December 31, 2019) (+)
|
||
Company Retirement Plan, as amended and restated, dated August 27, 2020 (Incorporated by reference to exhibit 10.13 filed with the Company’s Annual
Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2020) (+)
|
||
Company Supplemental Retirement Plan, amended and restated effective December 31, 2008 (Incorporated by reference to exhibit 10.13 filed with the
Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2009) (+)
|
||
First Amendment to Company Supplemental Retirement Plan, as amended and restated, dated December 22, 2014 (Incorporated by reference to exhibit
10.14(a) filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2014)(+)
|
||
Second Amendment to Company Supplemental Retirement Plan, as amended and restated, dated December 20, 2019 (Incorporated by reference to exhibit
10.14(b) filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2019) (+)
|
||
Company Savings and Investment Plan, as amended and restated, dated December 21, 2012 (Incorporated by reference to exhibit 10.14 filed with the
Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2012) (+)
|
||
Amendment to the Company Savings and Investment Plan, as amended and restated, dated December 5, 2013 (Incorporated by reference to exhibit 10.15(a)
filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2013) (+)
|
Amendment to the Company Savings and Investment Plan, as amended and restated, dated December 5, 2013 (Incorporated by reference to exhibit 10.15(b)
filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2013) (+)
|
||
Third Amendment to the Company Savings and Investment Plan, as amended and restated, dated December 22, 2014 (Incorporated by reference to exhibit
10.15(c) filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2014)(+)
|
||
Amendment to the Company Savings and Investment Plan, as amended and restated, dated December 31, 2015 (Incorporated by reference to exhibit 10.15(d)
filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2015)(+)
|
||
Amendment to the Company Savings and Investment Plan, as amended and restated, dated July 16, 2020 (Incorporated by reference to exhibit 10.1 filed
with the Company’s Quarterly Report on Form 10-Q (file no. 001-11430) for the quarter ended June 28, 2020)(+)
|
||
Amendment to the Company Savings and Investment Plan, as amended and restated, dated December 21, 2020 (Incorporated by reference to exhibit 10.15(f)
filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2020) (+)
|
||
Amendment to the Company Savings and Investment Plan, as amended and restated, dated May 25, 2022 (Incorporated by reference to exhibit 10.1 filed
with the Company’s Quarterly Report on Form 10-Q (file no. 001-11430) for the quarter ended July 3, 2022) (+)
|
||
Amendment to the Company Savings and Investment Plan, as amended and restated, dated December 15, 2022 (Incorporated by reference to exhibit 10.14(h)
filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2022) (+)
|
||
Company Supplemental Savings Plan, amended and restated effective December 31, 2008 (Incorporated by reference to exhibit 10.15 filed with the
Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2009) (+)
|
||
Amendment to the Company Supplemental Savings Plan, dated December 28, 2011 (Incorporated by reference to exhibit 10.16(a) filed with the Company’s
Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2011)(+)
|
||
First Amendment to the Company Supplemental Savings Plan, dated December 22, 2014 (Incorporated by reference to exhibit 10.16(b) filed with the
Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2014)(+)
|
||
Second Amendment to the Company Supplemental Savings Plan, dated December 22, 2014 (Incorporated by reference to exhibit 10.16(c) filed with the
Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2014)(+)
|
||
Third Amendment to the Company Supplemental Savings Plan, dated December 16, 2016 (Incorporated by reference to exhibit 10.16(d) filed with the
Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2016)(+)
|
||
Fourth Amendment to the Company Supplemental Savings Plan, dated December 20, 2019 (Incorporated by reference to exhibit 10.16(e) filed with the
Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2019) (+)
|
||
Company Health and Welfare Plan, effective as of April 1, 2003 and amended and restated as of January 1, 2006 (Incorporated by reference to exhibit
10.14 filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2006)(+)
|
||
Amendment to the Company Health and Welfare Plan, dated May 19, 2009 (Incorporated by reference to exhibit 10.16(a) filed with the Company’s Annual
Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2009) (+)
|
||
First Amendment to Company Health and Welfare Plan, dated December 22, 2014 (Incorporated by reference to exhibit 10.17(b) filed with the Company’s
Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2014)(+)
|
||
Company Retiree Medical Plan, effective as of January 1, 2011 (Incorporated by reference to exhibit 10.17 filed with the Company’s Annual Report on
Form 10-K (file no. 001-11430) for the year ended December 31, 2010)(+)
|
||
First Amendment to Company Retiree Medical Plan, dated December 22, 2014 (Incorporated by reference to exhibit 10.18(a) filed with the Company’s
Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2014)(+)
|
||
Second Amendment to Company Retiree Medical Plan, dated November 10, 2021 (Incorporated by reference to exhibit 10.18(b) filed with the Company’s
Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2021) (+)
|
||
Amended and Restated Grantor Trust Agreement, dated as of April 1, 2010, by and between the Company and the Wilmington Trust Company (Incorporated by
reference to exhibit 10.1 filed with the Company’s Quarterly Report on Form 10-Q (file no. 001-11430) for the period ended April 4, 2010)(+)
|
||
Agreement and Amendment No. 1, dated October 1, 2017, to the Amended and Restated Grantor Trust Agreement, dated as of April 1, 2010, by and between
the Company and the Wilmington Trust Company (Incorporated by reference to exhibit 10.19(a) filed with the Company’s Annual Report on Form 10-K (file no. 001-11430) for the year ended December 31, 2017)(+)
|
Refinancing Facility Agreement and Incremental Facility Amendment dated as of November 26, 2024, among Minerals Technologies Inc., certain
subsidiaries party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent. (Incorporated by reference to the exhibit 10.1 filed with the Company’s Current Report on Form 8-K (file no. 001-11430) filed on
November 26, 2024)
|
||
10.20
|
Indenture, dated July 22, 1963, between the Cork Harbour Commissioners and Roofchrome Limited (Incorporated by reference to the exhibit so designated
filed with the Company’s Registration Statement on Form S-1 (Registration No. 33-51292), originally filed on August 25, 1992)
|
|
Minerals Technologies Inc. Securities Trading Policy (*)
|
||
Subsidiaries of the Company (*)
|
||
Consent of Independent Registered Public Accounting Firm (*)
|
||
Power of Attorney (*)
|
||
Rule 13a-14(a)/15d-14(a) Certification executed by the Company’s principal executive officer (*)
|
||
Rule 13a-14(a)/15d-14(a) Certification executed by the Company’s principal financial officer (*)
|
||
Section 1350 Certification (*)
|
||
Information Concerning Mine Safety Violations (*)
|
||
Minerals Technologies Inc. Policy for Recoupment of Incentive Compensation (Incorporated by reference to exhibit 97 filed with the Company's Annual
Report on Form 10-K (file no. 001-11430 for the year ended December 31, 2023)
|
||
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the
Inline XBRL document)
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
|
(*) |
Filed herewith.
|
(+) |
Management contract or compensatory plan or arrangement required to be filed pursuant to Item 601 of Regulation S-K.
|
By:
|
/s/ Douglas T. Dietrich
|
||
Douglas T. Dietrich
|
|||
Chairman of the Board and Chief Executive Officer
|
SIGNATURE
|
TITLE
|
DATE
|
|||
/s/ Douglas T. Dietrich
|
Chairman of the Board and Chief Executive Officer
|
February 21, 2025
|
|||
Douglas T. Dietrich
|
(Principal Executive Officer)
|
||||
/s/ Erik C. Aldag
|
Senior Vice President – Finance and Treasury,
|
February 21, 2025
|
|||
Erik C. Aldag
|
Chief Financial Officer (Principal Financial Officer)
|
||||
/s/ Michael A. Cipolla
|
Vice President – Controller and
|
February 21, 2025
|
|||
Michael A. Cipolla
|
Chief Accounting Officer (Principal Accounting Officer)
|
||||
*
|
Director
|
February 21, 2025
|
|||
Joseph C. Breunig
|
|||||
*
|
Director
|
February 21, 2025
|
|||
John J. Carmola
|
|||||
*
|
Director
|
February 21, 2025
|
|||
Robert L. Clark
|
|||||
*
|
Director
|
February 21, 2025
|
|||
Alison A. Deans
|
|||||
/s/ Douglas T. Dietrich
|
Chairman
|
February 21, 2025
|
|||
Douglas T. Dietrich
|
|||||
*
|
Director
|
February 21, 2025
|
|||
Franklin L. Feder
|
|||||
*
|
Director
|
February 21, 2025
|
|||
Kristina M. Johnson
|
|||||
*
|
Director
|
February 21, 2025
|
|||
Rocky Motwani
|
|||||
*
|
Director
|
February 21, 2025
|
|||
Carolyn K. Pittman
|
|||||
*
|
Director
|
February 21, 2025
|
|||
Marc E. Robinson
|
|||||
*
|
By: /s/ Timothy J. Jordan
|
||||
Timothy J. Jordan
|
|||||
Attorney-in-Fact
|
Audited Financial Statements:
|
Page
|
|
Consolidated Balance Sheets as of December 31, 2024 and 2023
|
F-2
|
|
Consolidated Statements of Income for the years
ended December 31, 2024, 2023
and 2022
|
F-3
|
|
Consolidated Statements of Comprehensive Income
for the years ended December 31, 2024, 2023
and 2022
|
F-4
|
|
Consolidated Statements of Cash Flows for the years
ended December 31, 2024, 2023
and 2022
|
F-5
|
|
Consolidated Statements of Changes in Shareholders’ Equity for
the years ended December 31, 2024, 2023
and 2022
|
F-6
|
|
F-7
|
||
F-38
|
||
F-41
|
||
S-1
|
December 31,
|
||||||||
(millions of dollars, except share and per share amounts)
|
2024
|
2023
|
||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Short-term investments, at cost which approximates market
|
|
|
||||||
Accounts receivable
|
|
|
||||||
Inventories
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
Property, plant and equipment, less accumulated depreciation and depletion
|
|
|
||||||
Goodwill
|
|
|
||||||
Intangible assets
|
|
|
||||||
Deferred income taxes
|
|
|
||||||
Other assets and deferred charges
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Short-term debt
|
$
|
|
$
|
|
||||
Current maturities of long-term debt
|
|
|
||||||
Accounts payable
|
|
|
||||||
Income tax payable
|
|
|
||||||
Accrued compensation and related items
|
|
|
||||||
Other current liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Long-term debt, net of unamortized discount and deferred financing costs
|
|
|
||||||
Deferred income taxes
|
|
|
||||||
Accrued pension and postretirement benefits
|
|
|
||||||
Other non-current liabilities
|
|
|
||||||
Total liabilities
|
|
|
||||||
Shareholders’ equity:
|
||||||||
Preferred stock, without par value;
|
|
|
||||||
Common stock, par value at $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Less common stock held in treasury, at cost;
|
(
|
)
|
(
|
)
|
||||
Total Minerals Technologies Inc. shareholders’ equity
|
|
|
||||||
Non-controlling interests
|
|
|
||||||
Total shareholders’ equity
|
|
|
||||||
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars, except per share data)
|
2024
|
2023
|
2022
|
|||||||||
Net sales
|
$
|
|
$
|
|
$
|
|
||||||
Cost of goods sold
|
|
|
|
|||||||||
Production margin
|
|
|
|
|||||||||
Marketing and administrative expenses
|
|
|
|
|||||||||
Research and development expenses
|
|
|
|
|||||||||
Provision for credit losses
|
|
|
|
|||||||||
Restructuring and other items, net
|
|
|
|
|||||||||
Impairment of assets
|
|
|
|
|||||||||
Acquisition-related expenses
|
|
|
|
|||||||||
Gain on sale of assets, net
|
(
|
)
|
|
|
||||||||
Litigation expenses
|
|
|
|
|||||||||
Income from operations
|
|
|
|
|||||||||
Interest expense, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Debt extinguishment expenses
|
(
|
)
|
|
(
|
)
|
|||||||
Non-cash pension settlement charge
|
|
|
(
|
)
|
||||||||
Other non-operating deductions, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Total non-operating deductions, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Income before tax and equity in earnings
|
|
|
|
|||||||||
Provision for taxes on income
|
|
|
|
|||||||||
Equity in earnings of affiliates, net of tax
|
|
|
|
|||||||||
Net income
|
|
|
|
|||||||||
Less:
|
||||||||||||
Net income attributable to non-controlling interests
|
|
|
|
|||||||||
Net income attributable to Minerals Technologies Inc. (MTI)
|
$
|
|
$
|
|
$
|
|
||||||
Earnings per share:
|
||||||||||||
Basic:
|
||||||||||||
Income from operations attributable to MTI
|
$
|
|
$
|
|
$
|
|
||||||
Diluted:
|
||||||||||||
Income from operations attributable to MTI
|
$
|
|
$
|
|
$
|
|
||||||
Cash dividends declared per common share
|
$
|
|
$
|
|
$
|
|
||||||
Shares used in computation of earnings per share:
|
||||||||||||
Basic
|
|
|
|
|||||||||
Diluted
|
|
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Net income
|
$
|
|
$
|
|
$
|
|
||||||
Other comprehensive income (loss), net of tax:
|
||||||||||||
Foreign currency translation adjustments
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Pension and postretirement plan adjustments
|
|
|
|
|||||||||
Unrealized gain (loss) on cash flow hedges
|
|
(
|
)
|
|
||||||||
Total other comprehensive loss, net of tax
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Total comprehensive income including non-controlling interests
|
|
|
|
|||||||||
Less: Net income attributable to non-controlling interests
|
|
|
|
|||||||||
Less: Foreign currency translation adjustments attributable to non-controlling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Comprehensive income attributable to non-controlling interests
|
|
|
|
|||||||||
Comprehensive income attributable to Minerals Technologies Inc.
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Operating Activities:
|
||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
||||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||
Depreciation, depletion and amortization
|
|
|
|
|||||||||
Loss (gain) on disposal of property, plant and equipment
|
(
|
)
|
|
(
|
)
|
|||||||
Deferred income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Pension amortization and settlement loss
|
|
|
|
|||||||||
Provision for bad debts
|
|
|
|
|||||||||
Stock-based compensation
|
|
|
|
|||||||||
Impairment of assets
|
|
|
|
|||||||||
Provision for credit losses
|
|
|
|
|||||||||
Reduction of right of use asset
|
|
|
|
|||||||||
Non-cash debt extinguishment expenses
|
|
|
|
|||||||||
Restructuring costs
|
|
|
|
|||||||||
Other non-cash items
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Changes in operating assets and liabilities
|
||||||||||||
Accounts receivable
|
|
|
(
|
)
|
||||||||
Inventories
|
(
|
)
|
|
(
|
)
|
|||||||
Pension plan funding
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Accounts payable
|
|
(
|
)
|
|
||||||||
Restructuring liabilities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Income taxes payable
|
|
|
|
|||||||||
Prepaid expenses and other
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net cash provided by operating activities
|
|
|
|
|||||||||
Investing Activities:
|
||||||||||||
Purchases of property, plant and equipment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Cash paid for acquisitions, net of cash acquired
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Proceeds from sale of assets
|
|
|
|
|||||||||
Purchases of short-term investments
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Proceeds from sale of short-term investments
|
|
|
|
|||||||||
Other investing activities
|
(
|
)
|
|
|
||||||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Financing Activities:
|
||||||||||||
Long-term debt issuance
|
|
|
|
|||||||||
Debt issuance costs
|
(
|
)
|
|
(
|
)
|
|||||||
Repayment of long-term debt
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Proceeds from issuance of short-term debt
|
|
|
|
|||||||||
Repayment of short-term debt
|
(
|
)
|
(
|
)
|
|
|||||||
Purchase of common stock for treasury
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Proceeds from issuance of stock under option plan
|
|
|
|
|||||||||
Tax withholding payments for stock-based compensation
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Dividends paid to non-controlling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Cash dividends paid
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net cash provided by (used in) financing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Effect of exchange rate changes on cash and cash equivalents
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net increase (decrease) in cash and cash equivalents
|
|
|
(
|
)
|
||||||||
Cash and cash equivalents at beginning of period
|
|
|
|
|||||||||
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
$
|
|
||||||
Supplemental disclosure of cash flow information:
|
||||||||||||
Non-cash investing and financing activities
|
||||||||||||
Property, plant and equipment additions related to asset retirement obligations
|
$
|
|
$
|
|
$
|
|
||||||
Treasury stock purchases settled after period end
|
$
|
|
$
|
|
$
|
|
||||||
Excise tax charged to equity not paid
|
$
|
|
$
|
|
$
|
|
Equity Attributable to MTI
|
||||||||||||||||||||||||||||
(millions of dollars)
|
Common
Stock
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Treasury
Stock
|
Non-controlling
Interests
|
Total
|
|||||||||||||||||||||
Balance as of December 31, 2021
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Net income
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other comprehensive loss
|
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||
Dividends declared
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||
Dividends paid to non-controlling interests
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Issuance of shares pursuant to employee stock compensation plans
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Purchase of common stock for treasury
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
Stock-based compensation
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Conversion of RSU’s for tax withholding
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||||||||||||||||
Balance as of December 31, 2022
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Net income
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other comprehensive loss
|
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||
Dividends declared
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||
Dividends paid to non-controlling interests
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Issuance of shares pursuant to employee stock compensation plans
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Purchase of common stock for treasury
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
Stock-based compensation
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Conversion of RSU’s for tax withholding
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||||||||||||||||
Balance as of December 31, 2023
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Net income
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other comprehensive loss
|
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||
Dividends declared
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||
Dividends paid to non-controlling interests
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Issuance of shares pursuant to employee stock compensation plans
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Purchase of common stock for treasury
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
Stock-based compensation
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Conversion of RSU’s for tax withholding
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||||||||||||||||
Balance as of December 31, 2024
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Operating lease cost
|
$
|
|
$
|
|
$
|
|
||||||
Short-term lease cost
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
(millions of dollars)
|
December 31, 2024
|
|||
Operating cash flows information:
|
||||
Cash paid for amounts included in the measurement of lease liabilities
|
$
|
|
||
Non-cash activity:
|
||||
Right-of-use assets obtained in the exchange for operating lease liabilities
|
$
|
|
Weighted-average remaining operating lease term (in years)
|
|
|||
Weighted-average operating leases discount rate
|
|
%
|
December 31,
|
|||||||||
(millions of dollars)
|
Balance Sheet Classification
|
2024
|
2023
|
||||||
Right-of-use-asset
|
|
$
|
|
$
|
|
||||
Lease liability - current
|
|
|
|
||||||
Lease liability - non-current
|
|
|
|
(millions of dollars)
|
December 31, 2024
|
|||
2025
|
$
|
|
||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
2029
|
|
|||
Thereafter
|
|
|||
Total future minimum lease payments
|
|
|||
Less imputed interest
|
(
|
)
|
||
Total
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Net Sales
|
||||||||||||
Household & Personal Care
|
$
|
|
$
|
|
$
|
|
||||||
Specialty Additives
|
|
|
|
|||||||||
Consumer & Specialties Segment
|
|
|
|
|||||||||
High-Temperature Technologies
|
|
|
|
|||||||||
Environmental & Infrastructure
|
|
|
|
|||||||||
Engineered Solutions Segment
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
Restructuring and Other Items, net
|
Year Ended December 31,
|
|||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Asset Write-Downs
|
||||||||||||
Consumer & Specialties
|
$
|
|
$
|
|
$
|
|
||||||
Total asset write-down charges
|
$
|
|
$
|
|
$
|
|
||||||
Severance and other employee costs
|
||||||||||||
Consumer & Specialties
|
$
|
|
$
|
|
$
|
|
||||||
Engineered Solutions
|
|
|
|
|||||||||
Corporate
|
|
|
|
|||||||||
Total severance and other employee costs
|
$
|
|
$
|
|
$
|
|
||||||
Total restructuring and other items, net
|
$
|
|
$
|
|
$
|
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Restructuring liability, beginning of period
|
$
|
|
$
|
|
||||
Additional provisions
|
|
|
||||||
Cash payments
|
(
|
)
|
(
|
)
|
||||
Other
|
|
(
|
)
|
|||||
Restructuring liability, end of period
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
2024
|
2023
|
2022
|
||||||||||
Expected life (in years)
|
|
|
|
|||||||||
Interest rate
|
|
%
|
|
%
|
|
%
|
||||||
Volatility
|
|
%
|
|
%
|
|
%
|
||||||
Expected dividend yield
|
|
%
|
|
%
|
|
%
|
Awards
|
Weighted Average
Exercise Price
per Share
|
Weighted Average
Remaining Contractual
Life (Years)
|
Aggregate
Intrinsic Value
(Millions)
|
|||||||||||||
Awards outstanding at December 31, 2023
|
|
$
|
|
|||||||||||||
Granted
|
|
|
||||||||||||||
Exercised
|
(
|
)
|
|
|||||||||||||
Canceled
|
(
|
)
|
|
|||||||||||||
Expired
|
|
|
||||||||||||||
Awards outstanding at December 31, 2024
|
|
$
|
|
|
$
|
|
||||||||||
Awards exercisable at December 31, 2024
|
|
$
|
|
|
$
|
|
Awards
|
Weighted Average
Grant Date Fair
Value per Share
|
|||||||
Nonvested awards outstanding at December 31, 2023
|
|
$
|
|
|||||
Granted
|
|
|
||||||
Vested
|
(
|
)
|
|
|||||
Canceled
|
(
|
)
|
|
|||||
Nonvested awards outstanding at December 31, 2024
|
|
$
|
|
Awards
|
Weighted Average
Grant Date Fair
Value per Share
|
|||||||
Unvested balance at December 31, 2023
|
|
$
|
|
|||||
Granted
|
|
|
||||||
Vested
|
(
|
)
|
|
|||||
Canceled
|
(
|
)
|
|
|||||
Unvested balance at December 31, 2024
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(in millions, except per share data)
|
2024
|
2023
|
2022
|
|||||||||
Net income attributable to MTI
|
$
|
|
$
|
|
$
|
|
||||||
Weighted average shares outstanding
|
|
|
|
|||||||||
Dilutive effect of stock options and deferred restricted stock units
|
|
|
|
|||||||||
Weighted average shares outstanding, adjusted
|
|
|
|
|||||||||
Basic earnings per share attributable to MTI
|
$
|
|
$
|
|
$
|
|
||||||
Diluted earnings per share attributable to MTI
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Income (loss) from operations before income taxes and income from affiliates and joint ventures:
|
||||||||||||
Domestic
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
Foreign
|
|
|
|
|||||||||
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Domestic
|
||||||||||||
Taxes currently payable
|
||||||||||||
Federal
|
$
|
|
$
|
|
$
|
|
||||||
State and local
|
|
|
|
|||||||||
Deferred income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Domestic tax provision (benefit)
|
|
(
|
)
|
|
||||||||
Foreign
|
||||||||||||
Taxes currently payable
|
|
|
|
|||||||||
Deferred income taxes
|
|
(
|
)
|
(
|
)
|
|||||||
Foreign tax provision
|
|
|
|
|||||||||
Total tax provision
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
2024
|
2023
|
2022
|
||||||||||
U.S. statutory rate
|
|
%
|
|
%
|
|
%
|
||||||
Depletion
|
(
|
)%
|
(
|
)%
|
(
|
)%
|
||||||
Difference between tax provided on foreign earnings and the U.S. statutory rate
|
|
%
|
|
%
|
|
%
|
||||||
Global Intangible Low-Tax Income (GILTI)
|
|
%
|
|
%
|
|
%
|
||||||
Foreign Derived Intangible Income
|
(
|
)%
|
(
|
)%
|
|
|||||||
State and local taxes, net of federal tax benefit
|
|
%
|
(
|
)%
|
(
|
)%
|
||||||
Tax credits
|
(
|
)%
|
(
|
)%
|
(
|
)%
|
||||||
Bankruptcy Funding
|
|
%
|
|
|
||||||||
Impact of uncertain tax positions
|
(
|
)%
|
|
%
|
(
|
)%
|
||||||
Impact of officer’s non-deductible compensation
|
|
%
|
|
%
|
|
%
|
||||||
Foreign Withholding Tax
|
|
%
|
|
%
|
|
%
|
||||||
Other
|
|
%
|
|
%
|
|
%
|
||||||
Consolidated effective tax rate
|
|
%
|
|
%
|
|
%
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Deferred tax assets attributable to:
|
||||||||
Accrued liabilities
|
$
|
|
$
|
|
||||
Net operating loss carry forwards
|
|
|
||||||
Pension and post-retirement benefits costs
|
|
|
||||||
Interest
|
|
|
||||||
Research and development capitalization
|
|
|
||||||
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
Other
|
|
|
||||||
Total deferred tax assets
|
|
|
||||||
Deferred tax liabilities attributable to:
|
||||||||
Plant and equipment, principally due to differences in depreciation
|
|
|
||||||
Intangible assets
|
|
|
||||||
Other
|
|
|
||||||
Total deferred tax liabilities
|
|
|
||||||
Net deferred tax liability
|
$
|
(
|
)
|
$
|
(
|
)
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Net deferred tax asset, long-term
|
$
|
|
$
|
|
||||
Net deferred tax liability, long-term
|
|
|
||||||
Net deferred tax liability, long-term
|
$
|
(
|
)
|
$
|
(
|
)
|
(millions of dollars)
|
2024
|
2023
|
||||||
Balance at beginning of the year
|
$
|
|
$
|
|
||||
Increases related to current year tax positions
|
|
|
||||||
Decreases related to audit settlements and statute expirations
|
(
|
)
|
(
|
)
|
||||
Balance at the end of the year
|
$
|
|
$
|
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Raw materials
|
$
|
|
$
|
|
||||
Work-in-process
|
|
|
||||||
Finished goods
|
|
|
||||||
Packaging and supplies
|
|
|
||||||
Total inventories
|
$
|
|
$
|
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Mineral rights and reserves
|
$
|
|
$
|
|
||||
Land
|
|
|
||||||
Buildings
|
|
|
||||||
Machinery and equipment
|
|
|
||||||
Furniture and fixtures and other
|
|
|
||||||
Construction in progress
|
|
|
||||||
|
|
|||||||
Less: accumulated depreciation and depletion
|
(
|
)
|
(
|
)
|
||||
Property, plant and equipment, net
|
$
|
|
$
|
|
(millions of dollars)
|
Consumer & Specialties
|
Engineered Solutions
|
Consolidated
|
|||||||||
Balance at December 31, 2022
|
$
|
|
$
|
|
$
|
|
||||||
Change in goodwill relating to:
|
||||||||||||
Foreign exchange translation
|
(
|
)
|
|
(
|
)
|
|||||||
Total Changes
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
Balance at December 31, 2023
|
$
|
|
$
|
|
$
|
|
||||||
Change in goodwill relating to:
|
||||||||||||
Foreign exchange translation
|
|
(
|
)
|
|
||||||||
Total Changes
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
Balance at December 31, 2024
|
$
|
|
$
|
|
$
|
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||||||
(in millions of dollars)
|
(in millions of dollars)
|
|||||||||||||||||||
Weighted Average
Useful Life
(Years)
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
||||||||||||||||
Tradenames
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
Technology
|
|
|
|
|
|
|||||||||||||||
Patents and trademarks
|
|
|
|
|
|
|||||||||||||||
Customer relationships
|
|
|
|
|
|
|||||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
● |
Market approach – prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
|
● |
Cost approach – amount that would be required to replace the service capacity of an asset or replacement cost.
|
● |
Income approach – techniques to convert future amounts to a single present amount based on market expectations, including present value techniques, option-pricing and other models.
|
(millions of dollars)
|
Fair Value Measurements Using
|
|||||||||||||||
Asset /
(Liability)
Balance at
|
Quoted Prices in
Active Markets for
Identical Assets
|
Significant
Other Observable
Inputs
|
Significant
Unobservable
Inputs
|
|||||||||||||
Description
|
December 31, 2024
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||||||
Deferred compensation plan assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Supplementary pension plan assets
|
|
|
|
|
||||||||||||
Interest rate swap
|
|
|
|
|
Fair Value Measurements Using
|
||||||||||||||||
Asset /
(Liability)
Balance at
|
Quoted Prices in
Active Markets for
Identical Assets
|
Significant
Other Observable
Inputs
|
Significant
Unobservable
Inputs
|
|||||||||||||
Description
|
December 31, 2023
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||||||
Deferred compensation plan assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Supplementary pension plan assets
|
|
|
|
|
||||||||||||
Interest rate swap
|
(
|
)
|
|
(
|
)
|
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Secured Credit Agreement:
|
||||||||
Term Loan due 2031, net of unamortized deferred financing cost and original issue discount of $
|
$
|
|
$
|
|
||||
Previous Secured Credit Agreement:
|
||||||||
Term Loan due 2027, net of unamortized deferred financing cost of $
|
|
|
||||||
Senior Notes:
|
||||||||
|
|
|
||||||
Other debt
|
|
|
||||||
Total
|
$
|
|
$
|
|
||||
Less: Current maturities
|
|
|
||||||
Long-term debt
|
$
|
|
$
|
|
Pension Benefits
|
Post-Retirement Benefits
|
|||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2024
|
2023
|
||||||||||||
Change in benefit obligations:
|
||||||||||||||||
Beginning projected benefit obligation
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Service cost
|
|
|
|
|
||||||||||||
Interest cost
|
|
|
|
|
||||||||||||
Actuarial loss (gain)
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
Settlements
|
|
(
|
)
|
|
|
|||||||||||
Foreign exchange impact
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Other
|
|
|
|
|
||||||||||||
Ending projected benefit obligation
|
|
|
|
|
||||||||||||
Change in plan assets:
|
||||||||||||||||
Beginning fair value
|
|
|
|
|
||||||||||||
Actual return on plan assets
|
|
|
|
|
||||||||||||
Employer contributions
|
|
|
|
|
||||||||||||
Plan participants’ contributions
|
|
|
|
|
||||||||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
Settlements
|
|
(
|
)
|
|
|
|||||||||||
Foreign exchange impact
|
(
|
)
|
|
|
|
|||||||||||
Ending fair value
|
|
|
|
|
||||||||||||
Funded status
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
Pension Benefits
|
Post-Retirement Benefits
|
|||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2024
|
2023
|
||||||||||||
Non-current asset
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Current liability
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Non-current liability
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Net liability recognized
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
Pension Benefits
|
Post-Retirement Benefits
|
|||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2024
|
2023
|
||||||||||||
Net actuarial (gain) loss
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
Prior service cost
|
|
|
|
|
||||||||||||
Amount recognized end of year
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
Pension Benefits
|
Post-Retirement Benefits
|
|||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2024
|
2023
|
||||||||||||
Current year actuarial gain (loss)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||||
Amortization of actuarial (gain) loss
|
|
|
(
|
)
|
(
|
)
|
||||||||||
Total recognized in other comprehensive income
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
Pension Benefits
|
Post-Retirement Benefits
|
|||||||||||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
||||||||||||||||||
Service cost
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Interest cost
|
|
|
|
|
|
|
||||||||||||||||||
Expected return on plan assets
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||||||||
Recognized net actuarial (gain) loss
|
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||||||||
Settlement/curtailment (gain) loss
|
|
|
|
|
|
|
||||||||||||||||||
Net periodic benefit cost
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
Year Ended December 31,
|
||||||||||||
2024
|
2023
|
2022
|
||||||||||
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
Expected return on plan assets
|
|
%
|
|
%
|
|
%
|
||||||
Rate of compensation increase
|
|
%
|
|
%
|
|
%
|
||||||
Interest crediting rate
|
|
%
|
|
%
|
|
%
|
Year Ended December 31,
|
||||||||||||
2024
|
2023
|
2022
|
||||||||||
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
Rate of compensation increase
|
|
%
|
|
%
|
|
%
|
December 31,
|
||||||||
2024
|
2023
|
|||||||
Asset Category
|
||||||||
Equity securities
|
|
%
|
|
%
|
||||
Fixed income securities
|
|
%
|
|
%
|
||||
Real estate
|
|
%
|
|
%
|
||||
Other
|
|
%
|
|
%
|
||||
Total
|
|
%
|
|
%
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Asset Category
|
||||||||
Equity securities
|
$
|
|
$
|
|
||||
Fixed income securities
|
|
|
||||||
Real estate
|
|
|
||||||
Other
|
|
|
||||||
Total
|
$
|
|
$
|
|
U.S. Plans
|
International Plans
|
|||||||||||||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
2024
|
2023
|
2022
|
||||||||||||||||||
Fair value of plan assets
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Quoted Prices in
Active Markets for
Identical Assets
|
Significant
Other Observable
Inputs
|
Significant
Unobservable
Inputs
|
||||||||||||||
(millions of dollars)
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
||||||||||||
Pension Assets Fair Value as of December 31, 2024
|
||||||||||||||||
Equity securities
|
||||||||||||||||
US equities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Non-US equities
|
|
|
|
|
||||||||||||
Fixed income securities
|
||||||||||||||||
Corporate debt instruments
|
|
|
|
|
||||||||||||
Real estate and other
|
||||||||||||||||
Real estate
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
|
Quoted Prices in
Active Markets for
Identical Assets
|
Significant
Other Observable
Inputs
|
Significant
Unobservable
Inputs
|
||||||||||||||
(millions of dollars)
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
||||||||||||
Pension Assets Fair Value as of December 31, 2023
|
||||||||||||||||
Equity securities
|
||||||||||||||||
US equities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Non-US equities
|
|
|
|
|
||||||||||||
Fixed income securities
|
||||||||||||||||
Corporate debt instruments
|
|
|
|
|
||||||||||||
Real estate and other
|
||||||||||||||||
Real estate
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
|
(millions of dollars)
|
||||
Beginning balance at December 31, 2022
|
$
|
|
||
Purchases, sales, settlements
|
|
|||
Actual (loss) return on plan assets still held at reporting date
|
(
|
)
|
||
Foreign exchange impact
|
|
|||
Ending balance at December 31, 2023
|
$
|
|
||
Purchases, sales, settlements
|
|
|||
Actual (loss) return on plan assets still held at reporting date
|
(
|
)
|
||
Foreign exchange impact
|
|
|||
Ending balance at December 31, 2024
|
$
|
|
(millions of dollars)
|
Pension Benefits
|
Other Benefits
|
||||||
2025
|
$
|
|
$
|
|
||||
2026
|
$
|
|
$
|
|
||||
2027
|
$
|
|
$
|
|
||||
2028
|
$
|
|
$
|
|
||||
2029
|
$
|
|
$
|
|
||||
2030-2034
|
$
|
|
$
|
|
Three Months Ended
|
Twelve Months Ended
|
|||||||||||||||
(number of claims)
|
Dec. 31,
2024
|
Dec. 31,
2023
|
Dec. 31,
2024
|
Dec. 31,
2023
|
||||||||||||
Claims pending, beginning of period
|
|
|
|
|
||||||||||||
Claims filed
|
|
|
|
|
||||||||||||
Less: Claims dismissed, settled or otherwise resolved
|
|
|
|
|
||||||||||||
Claims pending, end of period
|
|
|
|
|
Stock Options
|
Restricted Stock Units
|
|||||||||||||||||||
Shares
Available
for Grant
|
Shares
|
Weighted Average
Exercise Price
per Share ($)
|
Shares
|
Weighted Average
Exercise Price
per Share ($)
|
||||||||||||||||
Balance January 1, 2022
|
|
|
$
|
|
|
$
|
|
|||||||||||||
Granted
|
(
|
)
|
|
|
|
|
||||||||||||||
Exercised/vested
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||
Canceled
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||
Balance December 31, 2022
|
|
|
|
|
|
|||||||||||||||
Granted
|
(
|
)
|
|
|
|
|
||||||||||||||
Exercised/vested
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||
Canceled
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||
Balance December 31, 2023
|
|
|
|
|
|
|||||||||||||||
Authorized
|
|
—
|
—
|
—
|
—
|
|||||||||||||||
Granted
|
(
|
)
|
|
|
|
|
||||||||||||||
Exercised/vested
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||
Canceled
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||
Balance December 31, 2024
|
|
|
$
|
|
|
$
|
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Cumulative foreign currency translation
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Unrecognized pension benefit (costs) (net of tax (expense) benefit of $(
|
|
(
|
)
|
|||||
Unrealized gain on cash flow hedges (net of tax expense (benefit) of $
|
|
|
||||||
$
|
(
|
)
|
$
|
(
|
)
|
Year Ended December 31,
|
||||||||||||||||||||||||||||||||||||
2024
|
2023
|
2022
|
||||||||||||||||||||||||||||||||||
(millions of dollars)
|
Pre-Tax
Amount
|
Tax
(Expense)
Benefit
|
Net-of-
Tax
Amount
|
Pre-Tax
Amount
|
Tax
(Expense)
Benefit
|
Net-of-
Tax
Amount
|
Pre-Tax
Amount
|
Tax
(Expense)
Benefit
|
Net-of-
Tax
Amount
|
|||||||||||||||||||||||||||
Foreign currency translation adjustment
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||||||||
Pension plans:
|
||||||||||||||||||||||||||||||||||||
Net actuarial gains (losses) and prior service costs arising during the period
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
||||||||||||||||||||||||
Amortization of net actuarial (gains) losses and prior service costs
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
||||||||||||||||||||||||
Unrealized gains (losses) on cash flow hedges
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||||||
Total other comprehensive income (loss)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
December 31,
|
||||||||
(millions of dollars)
|
2024
|
2023
|
||||||
Asset retirement obligation, beginning of period
|
$
|
|
$
|
|
||||
Accretion expense
|
|
|
||||||
Other
|
|
(
|
)
|
|||||
Payments
|
(
|
)
|
(
|
)
|
||||
Foreign currency translation
|
(
|
)
|
(
|
)
|
||||
Asset retirement obligation, end of period
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||||||||||||||
2024
|
2023
|
|||||||||||||||||||||||
(millions of dollars)
|
Consumer &
Specialties
|
Engineered
Solutions
|
Total
|
Consumer &
Specialties
|
Engineered
Solutions
|
Total
|
||||||||||||||||||
Net Sales
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Cost of goods sold
|
|
|
|
|
|
|
||||||||||||||||||
Segment production margin
|
|
|
|
|
|
|
||||||||||||||||||
Marketing and administrative expenses
|
|
|
|
|
|
|
||||||||||||||||||
Research and development expenses
|
|
|
|
|
|
|
||||||||||||||||||
Gain on sale of assets, net
|
|
(
|
)
|
(
|
)
|
|
|
|
||||||||||||||||
Impairment of assets
|
|
|
|
|
|
|
||||||||||||||||||
Restructuring and other items, net
|
|
|
|
|
|
|
||||||||||||||||||
Litigation expenses
|
|
|
|
|
|
|
||||||||||||||||||
Segment income from operations
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
2022
|
||||||||||||
(millions of dollars)
|
Consumer &
Specialties
|
Engineered
Solutions
|
Total
|
|||||||||
Net Sales
|
$
|
|
$
|
|
$
|
|
||||||
Cost of goods sold
|
|
|
|
|||||||||
Segment production margin
|
|
|
|
|||||||||
Marketing and administrative expenses
|
|
|
|
|||||||||
Research and development expenses
|
|
|
|
|||||||||
Acquisition-related expenses
|
|
|
|
|||||||||
Litigation expenses
|
|
|
|
|||||||||
Segment income from operations
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Segment income from operations
|
$
|
|
$
|
|
$
|
|
||||||
Interest expense, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Other non-operating deductions, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Unallocated expenses:
|
||||||||||||
Provision for credit losses
|
|
|
|
|||||||||
Restructuring and other items, net
|
|
|
|
|||||||||
Acquisition-related expenses
|
|
|
|
|||||||||
Litigation expenses
|
|
|
|
|||||||||
Unallocated corporate expenses
|
|
|
|
|||||||||
Debt extinguishment expenses
|
(
|
)
|
|
(
|
)
|
|||||||
Non-cash pension settlement charge
|
|
|
(
|
)
|
||||||||
Income before tax and equity in earnings
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Depreciation, Depletion and Amortization
|
||||||||||||
Consumer & Specialties
|
$
|
|
$
|
|
$
|
|
||||||
Engineered Solutions
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
||||||
Segment Assets
|
||||||||||||
Consumer & Specialties
|
$
|
|
$
|
|
$
|
|
||||||
Engineered Solutions
|
|
|
|
|||||||||
Corporate
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
||||||
Capital Expenditures
|
||||||||||||
Consumer & Specialties
|
$
|
|
$
|
|
$
|
|
||||||
Engineered Solutions
|
|
|
|
|||||||||
Corporate
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Net Sales
|
||||||||||||
United States
|
$
|
|
$
|
|
$
|
|
||||||
Canada/Latin America
|
|
|
|
|||||||||
Europe/Africa
|
|
|
|
|||||||||
Asia
|
|
|
|
|||||||||
Total International
|
$
|
|
$
|
|
$
|
|
||||||
Consolidated net sales
|
$
|
|
$
|
|
$
|
|
||||||
Long-Lived Assets
|
||||||||||||
United States
|
$
|
|
$
|
|
$
|
|
||||||
Canada/Latin America
|
|
|
|
|||||||||
Europe/Africa
|
|
|
|
|||||||||
Asia
|
|
|
|
|||||||||
Total International
|
$
|
|
$
|
|
$
|
|
||||||
Consolidated long-lived assets
|
$
|
|
$
|
|
$
|
|
Year Ended December 31,
|
||||||||||||
(millions of dollars)
|
2024
|
2023
|
2022
|
|||||||||
Household & Personal Care
|
$
|
|
$
|
|
$
|
|
||||||
Specialty Additives
|
|
|
|
|||||||||
High-Temperature Technologies
|
|
|
|
|||||||||
Environmental & Infrastructure
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
● |
evaluating the professional qualifications, knowledge, skills, and ability of the Company’s external specialist used in compiling and evaluating claims data
|
● |
assessing the talc related legal cases settled during the year and the open cases as of December 31, 2024, by evaluating letters obtained directly from the Company’s
external and internal legal counsel
|
● |
testing a selection of claims data used in the Company’s talc accrual calculation by comparing the selected items to underlying claims documentation
|
● |
discussing the status and processing of significant known, actual, and potential litigation, and the status of ongoing Oldco bankruptcy proceedings with the Company’s
in-house legal counsel, as well as external counsel
|
● |
evaluating management’s assessment regarding whether an unfavorable outcome is reasonably possible or probable and reasonably estimable.
|
/s/ Douglas T. Dietrich
Chairman of the Board and Chief Executive Officer
|
/s/ Erik C. Aldag
Senior Vice President, Finance and Treasury, Chief Financial Officer
|
|
/s/ Michael A. Cipolla
Vice President, Corporate Controller and Chief Accounting Officer
|
Description
|
Balance at
Beginning of Period
|
Additions Charged to Costs,
Provisions and Expenses
|
Deductions (a)
|
Balance at
End of Period
|
||||||||||||
Year Ended December 31, 2024
|
||||||||||||||||
Valuation and qualifying accounts deducted from assets to which they apply:
|
||||||||||||||||
Allowance for doubtful accounts
|
$
|
|
|
(
|
)
|
$
|
|
|||||||||
Year Ended December 31, 2023
|
||||||||||||||||
Valuation and qualifying accounts deducted from assets to which they apply:
|
||||||||||||||||
Allowance for doubtful accounts
|
$
|
|
|
|
$
|
|
||||||||||
Year Ended December 31, 2022
|
||||||||||||||||
Valuation and qualifying accounts deducted from assets to which they apply:
|
||||||||||||||||
Allowance for doubtful accounts
|
$
|
|
|
(
|
)
|
$
|
|
(a) |
|